LAPAROSCOPIC APPROACH IN RECTAL CANCER SURGERY: A RETROSPECTIVE SINGLE-CENTER STUDY ANALYSIS OF CLINICAL OUTCOMES

Authors

  • F. C. STANCULEA Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
  • C. O. UNGUREANU Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
  • O. GINGHINA Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
  • N. IORDACHE Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
  • V. T. GRIGOREAN Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
  • M. LITESCU Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

DOI:

https://doi.org/10.22551/MSJ.2026.02.13

Abstract

Along with total neoadjuvant therapy (TNT), surgical resection is the cornerstone of rectal cancer treatment. Minimally invasive techniques include: laparoscopic, robotic, transanal total mesorectal excision and transluminal local excision. In this study, we evaluated the feasibility and outcomes of laparoscopic surgery for rectal cancer in a single-center cohort. Materials and methods: We conducted a retrospective analysis of consecutive patients, who underwent surgical treatment for primary rectal cancer at a tertiary institution. A total of 99 patients were included and divided in two groups: laparoscopic (66 patients) and open (33 patients). Clinical and perioperative variables analyzed included age, sex, body mass index, comorbidities, tumor location, surgical technique, length of hospital stay, and postoperative complications. Results: The mean age was 68.9 years. Laparoscopy was performed in 66.7% of the patients (conversion to open resection - 15.1%) and was applicable across all age groups. Approximately half of the cases were cancers of the upper rectum. Patients underwent low anterior resection in 61.61%, 24.24% underwent abdominoperineal resection, 14.14% underwent resection with colostomy, and all cases were elective. The median length of hospital stay was 10 days in the laparoscopic group and 11 days in the open surgery group; however, no significant differences were observed between the two groups (p=0.287). According to the Clavien-Dindo classification, for the laparoscopic group, the complications were distributed as grade I (n = 12), grade II (n = 5), and grade III (n = 4); for the open group, grade I (n = 5). Anastomotic leakage (AL) was present in <10 % of cases. Conclusions: Rectal cancer is a complex disease that presents oncological, anatomical and functional challenges, which are addressed using a variety of surgical modalities. Our study demonstrates that the laparoscopic approach in rectal cancer is feasible regardless of age and tumor location, and showed a trend toward shorter hospital stay, the difference was not statistically significant.

Author Biographies

  • F. C. STANCULEA, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

    Sf. Ioan Clinical Hospital of Emergency, Bucharest, Romania

  • C. O. UNGUREANU, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

    Sf. Ioan Clinical Hospital of Emergency, Bucharest, Romania

  • O. GINGHINA, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

    Prof. Dr. Al. Trestioreanu Oncological Institute, Bucharest, Romania

  • N. IORDACHE, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

    Sf. Ioan Clinical Hospital of Emergency, Bucharest, Romania
    The Academy of Romanian Scientists, Bucharest, Romania

  • V. T. GRIGOREAN, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

    Bagdasar-Arseni Clinical Emergency Hospital, Bucharest, Romania

  • M. LITESCU, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

    Sf. Ioan Clinical Hospital of Emergency, Bucharest, Romania

References

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61(2): 69-90 / Erratum in: CA Cancer J Clin 2011; 61(2): 134.

2. Vallicelli C, Barbara SJ, Fabbri E, Perrina D, Griggio G, Agnoletti V, Catena F. Geriatric Approaches to Rectal Cancer: Moving Towards a Patient-Tailored Treatment Era. Journal of Clinical Medicine 2025; 14(4): 1159 / doi: 10.3390/jcm14041159.

3. Zerey M, Hawver LM, Awad Z, Stefanidis D, Richardson W, Fanelli RD. Members of the SAGES Guidelines Committee. SAGES evidence-based guidelines for the laparoscopic resection of curable colon and rectal cancer. Surg Endosc 2013; 27(1): 1-10 / doi: 10.1007/ s00464-012-2592-x.

4. Rasool S, Kadla SA, Rasool V, Ganai BA. A comparative overview of general risk factors associated with the incidence of colorectal cancer. Tumour Biol 2013; 34(5): 2469-2476 / doi: 10.1007/s13277-013-0876-y.

5. Parker JM, Feldmann TF, Cologne KG. Advances in Laparoscopic Colorectal Surgery. Surg Clin North Am 2017; 97(3): 547-560 / doi: 10.1016/j.suc.2017.01.005.

6. Reza MM, Blasco JA, Andradas E, Cantero R, Mayol J. Systematic review of laparoscopic vs. open surgery for colorectal cancer. Br J Surg 2006; 93(8): 921-928.

7. Prete, FD, Pezzolla A, Prete F, et al. Robotic vs. Laparoscopic Minimally Invasive Surgery for Rectal Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Annals of Surgery 2018; 267(6): 1034-1046.

8. ESMO Guidelines Committee. Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology 2025; 36(9): 1007-1024.

9. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240(2): 205-213.

10. Adam IJ, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. The Lancet 1994; 344(8924): 707-711.

11. Jeong, Seung-Yong, et al. Open vs. laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. Lancet Oncology 2014; 15(7): 767-774.

12. Fleshman J, Sargent DJ, Green E, et al. Clinical Outcomes of Surgical Therapy Study Group. Laparo-scopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial. Ann Surg 2007; 246(4): 655-662.

13. Stevenson, Andrew RL, et al. Effect of laparoscopic-assisted resection vs open resection on patholog-ical outcomes in rectal cancer: the ALaCaRT randomized clinical trial. Jama 2015; 314.13: 1356-1363.

14. Fleshman, James, et al. Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. Jama 2015; 314.13: 1346-1355.

15. Crippa J, Grass F, Achilli P, et al. Risk factors for conversion in laparoscopic and robotic rectal cancer surgery. Br J Surg 2020; 107: 560-566.

16. Martínez-Pérez A, Carra MC, Brunetti F, de'Angelis N. Pathologic Outcomes of Laparoscopic vs Open Mesorectal Excision for Rectal Cancer: A Systematic Review and Meta-analysis. JAMA Surg 2017; 152(4): e165665.

17. Wang G, Ye K, Yang W, et al. Effect of Total Mesorectal Excision (TME) quality on 3-year overall survival in low rectal cancer based on the LASRE trial. Sci Rep 2025; 15: 41682

18. Peltrini R, Imperatore N, Carannante F, et al. Age and comorbidities do not affect short-term outcomes after laparoscopic rectal cancer resection in elderly patients. A multi-institutional cohort study in 287 patients. Updates Surg 2021; 73(2): 527-537.

19. Gutierrez L, Bonne A, Trilling B, et al. Impact of obesity on morbidity and oncologic outcomes after total mesorectal excision for mid and low rectal cancer. Tech Coloproctol 2023; 27(5): 407-418.

20. Qu H, Liu Y, Bi Ds. Clinical risk factors for anastomotic leakage after laparoscopic anterior resection for rectal cancer: a systematic review and meta-analysis. Surg Endosc 2015; 29: 3608-3617.

21. Yap R, Wilkins S, Staples M, Oliva K, McMurrick PJ. The Effect of Diabetes on the Perioperative Outcomes of Colorectal Cancer Surgery Patients. PLoS One 2016; 11(12): e0167271.

22. Chiarello MM, Fransvea P, Cariati M, Adams NJ, Bianchi V, Brisinda G. Anastomotic leakage in colorectal cancer surgery. Surg Oncol 2022; 40: 101708.

23. Vilallonga R, Stoica RA, Cotirlet A, Armengol M, Iordache N. Single incision laparoscopic surgery (SILS) cholecystectomy. A novel technique. Chirurgia (Bucur) 2010; 105(2): 239-241.

24. Hudiță A, Ioana-Lavric V, Zamfir A, et al. Optimization of a flow cytometry method for the approach of liquid biopsy as a therapy modulation tool in patients with colorectal cancer. Farmacia 2018; 66(5): 853-860.

25. Ungureanu CO, Ginghina O, Stanculea F, et al. Surgical Approach to Bilateral Inguinal Hernia. A Case-Control Study. Chirurgia (Bucur) 2023; 118(6): 642-653 / doi: 10.21614/chirurgia.2023.v.118.i.6.p. 642.

26. Vilallonga R, Sanchez Garcia JL, Armengol M, Iordache N. Jejunal diverticula causing massive intestinal bleeding. Chirurgia (Bucur) 2012; 107(5): 652-654.

Additional Files

Published

2026-06-01